Nevakar Injectables can proceed with equivalents theory against Baxter, US judge says
MLex Summary: A US magistrate judge in Delaware agreed with Baxter Healthcare that allegations its norepinephrine product does not literally, directly infringe five Nevakar Injectables patents fail, but said factual disputes...To view the full article, register now.
Already a subscriber? Click here to view full article